Impact of tenofovir vs. entecavir treatment on progression of chronic hepatitis B: A nationwide cohort study
Background & Aims: Conflicting evidence exists on hepatocellular carcinoma (HCC) risk in patients with chronic hepatitis B (CHB) receiving tenofovir vs. entecavir. We assessed the impacts of the two drugs on the clinical trajectory of CHB at a population level. Methods: We conducted a retrospect...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2025-10-01
|
| Seri Bilgileri: | JHEP Reports |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2589555925001892 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|